A New Route to the Synthesis of Phosphine-Substituted Diiron Aza- and Oxadithiolate Complexes

Lewis acid protection turns cyanide containing [FeFe]-hydrogenase mimics into proton reduction catalysts

Sustainable sources of hydrogen are a vital component of the envisioned energy transition. Understanding and mimicking the [FeFe]-hydrogenase provides a route to achieving this goal. In this study we re-visit a molecular mimic of the hydrogenase, the propyl dithiolate bridged complex [Fe₂(μ-pdt)(CO)₄(CN)₂]²⁻, in which the cyanide ligands are tuned via Lewis acid interactions. This system provides a rare example of a cyanide containing [FeFe]-hydrogenase mimic capable of catalytic proton reduction, as demonstrated by cyclic voltammetry. EPR, FTIR, UV-vis and X-ray absorption spectroscopy are employed to characterize the species produced by protonation, and reduction or oxidation of the complex. The results reveal that biologically relevant iron-oxidation states can be generated, potentially including short-lived mixed valent Fe(i)Fe(ii) species. We propose that catalysis is initiated by protonation of the diiron complex and the resulting di-ferrous bridging hydride species can subsequently follow two different pathways to promote H₂ gas formation depending on the applied reduction potential.

Mimicking the hydrogen-bonding interactions of the [FeFe]-hydrogenase active-site using Lewis acids transforms an otherwise unstable cyanide containing hydrogenase mimic into a proton reduction catalyst.

Easily Available, Amphiphilic Diiron Cyclopentadienyl Complexes Exhibit in Vitro Anticancer Activity in 2D and 3D Human Cancer Cells through Redox Modulation Triggered by CO Release

A straightforward two-step procedure via single CO removal allows the conversion of commercial [Fe2 Cp2 (CO)4 ] into a range of amphiphilic and robust ionic complexes based on a hybrid aminocarbyne/iminium ligand, [Fe2 Cp2 (CO)3 {CN(R)(R')}]X (R, R'=alkyl or aryl; X=CF3 SO3 or BF4 ), on up to multigram scales. Their physicochemical properties can be modulated by an appropriate choice of N-substituents and counteranion. Tested against a panel of human cancer cell lines, the complexes were shown to possess promising antiproliferative activity and to circumvent multidrug resistance. Interestingly, most derivatives also retained a significant cytotoxic activity against human cancer 3D cell cultures. Among them, the complex with R=4-C6 H4 OMe and R'=Me emerged as the best performer of the series, being on average about six times more active against cancer cells than a noncancerous cell line, and displayed IC50 values comparable to those of cisplatin in 3D cell cultures. Mechanistic studies revealed the ability of the complexes to release carbon monoxide and to act as oxidative stress inducers in cancer cells.

[FeFe]-Hydrogenases: maturation and reactivity of enzymatic systems and overview of biomimetic models

[FeFe]-hydrogenases recieved increasing interest in the last decades. This review summarises important findings regarding their enzymatic reactivity as well as inorganic models applied as electro- and photochemical catalysts.

Diiron azadithiolate clusters supported on carbon nanotubes for efficient electrocatalytic proton reduction

The first example of diiron azadithiolate clusters supported on carbon nanotubes (1-f-SWCNTs) was constructed via covalent attachment. This nanohybrid shows efficient electrocatalytic proton reduction with a TOF of 9444 s⁻¹ in 0.2 N aqueous H₂SO₄.

Phosphine-substituted Fe–Te clusters related to the active site of [FeFe]-H2ases

Mono-, di-, and tetranuclear phosphine-substituted Fe/Te clusters 1–6 were described.

Anticancer Potential of Diiron Vinyliminium Complexes

Although ferrocene derivatives have attracted considerable attention as possible anticancer agents, the medicinal potential of diiron complexes has remained largely unexplored. Herein, we describe the straightforward multigram-scale synthesis and the antiproliferative activity of a series of diiron cyclopentadienyl complexes containing bridging vinyliminium ligands. IC₅₀ values in the low-to-mid micromolar range were determined against cisplatin sensitive and resistant human ovarian carcinoma (A2780 and A2780cisR) cell lines. Notable selectivity towards the cancerous cells lines compared to the non-tumoral human embryonic kidney (HEK-293) cell line was observed for selected compounds. The activity seems to be multimodal, involving reactive oxygen species (ROS) generation and, in some cases, a fragmentation process to afford monoiron derivatives. The large structural variability, amphiphilic character and good stability in aqueous media of the diiron vinyliminium complexes provide favorable properties compared to other widely studied classes of iron-based anticancer candidates.